137 related articles for article (PubMed ID: 19201411)
21. Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
Aguilar-Salinas CA; Díaz-Polanco A; Quintana E; Macias N; Arellano A; Ramírez E; Ordóñez ML; Velásquez-Alva C; Gómez Pérez FJ; Alberú J; Correa-Rotter R
Am J Kidney Dis; 2002 Jul; 40(1):169-77. PubMed ID: 12087575
[TBL] [Abstract][Full Text] [Related]
22. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
[TBL] [Abstract][Full Text] [Related]
23. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Cortner JA; Coates PM; Liacouras CA; Jarvik GP
J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Haffner SM; Kushwaha RS; Hazzard WR
Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
[TBL] [Abstract][Full Text] [Related]
25. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of small, dense LDL cholesterol in patients with hyperlipidemia and type 2 diabetes].
Shishino K; Ochi M; Murase M; Osawa H; Makino H
Rinsho Byori; 2007 Aug; 55(8):705-11. PubMed ID: 17882792
[TBL] [Abstract][Full Text] [Related]
27. LDL physical and chemical properties in familial combined hyperlipidemia.
Hokanson JE; Krauss RM; Albers JJ; Austin MA; Brunzell JD
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):452-9. PubMed ID: 7749856
[TBL] [Abstract][Full Text] [Related]
28. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.
Hokanson JE; Austin MA; Zambon A; Brunzell JD
Arterioscler Thromb; 1993 Mar; 13(3):427-34. PubMed ID: 8443147
[TBL] [Abstract][Full Text] [Related]
29. Increased arterial stiffness in familial combined hyperlipidemia.
Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
[TBL] [Abstract][Full Text] [Related]
30. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
[TBL] [Abstract][Full Text] [Related]
31. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age).
Wiesbauer F; Blessberger H; Azar D; Goliasch G; Wagner O; Gerhold L; Huber K; Widhalm K; Abdolvahab F; Sodeck G; Maurer G; Schillinger M
Eur Heart J; 2009 May; 30(9):1073-9. PubMed ID: 19276196
[TBL] [Abstract][Full Text] [Related]
32. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
[TBL] [Abstract][Full Text] [Related]
33. Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
Yamazaki K; Bujo H; Taira K; Itou N; Shibasaki M; Takahashi K; Saito Y
Atherosclerosis; 2004 Jan; 172(1):181-7. PubMed ID: 14709374
[TBL] [Abstract][Full Text] [Related]
34. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
35. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
Koprovicová J; Kollár J; Petrásová D
Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
[TBL] [Abstract][Full Text] [Related]
36. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E
Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591
[TBL] [Abstract][Full Text] [Related]
37. Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia.
De Michele M; Iannuzzi A; Salvato A; Pauciullo P; Gentile M; Iannuzzo G; Panico S; Pujia A; Bond GM; Rubba P
Heart; 2007 Jan; 93(1):78-81. PubMed ID: 16807271
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
[TBL] [Abstract][Full Text] [Related]
39. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
[TBL] [Abstract][Full Text] [Related]
40. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
Reynisdottir S; Eriksson M; Angelin B; Arner P
J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
